Get complete Patent Opposition Report for Concert Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Concert Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP2635299Methods For Treating Hair Loss DisordersTHE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORKApr 30, 2020
EP3184526Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase InhibitorINCYTEJun 28, 2019

Explore Concert Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3450434Feb 24, 2021Deuterated Derivatives Of Ruxolitinib2